JUN 5, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Lidocaine Hydrochloride (Labeling)
U.S. Food and Drug Administration
This is an FDA supplemental approval action for labeling changes to an already-approved injectable lidocaine product; it documents a regulatory decision, not clinical trial evidence.
Reported
Approval date2026-06-05
Application typeANDA (Abbreviated New Drug Application) sup…
Active ingredientLidocaine Hydrochloride